PubMed:12626384 / 106-283 JSONTXT

Annnotations TAB JSON ListView MergeView

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":22,"end":127},"obj":"Sentence"},{"id":"T2","span":{"begin":22,"end":127},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T3","span":{"begin":41,"end":50},"obj":"FMAID:63836"},{"id":"_T4","span":{"begin":41,"end":50},"obj":"FMAID:162299"},{"id":"_T5","span":{"begin":111,"end":124},"obj":"FMAID:196789"},{"id":"_T6","span":{"begin":111,"end":124},"obj":"FMAID:82794"},{"id":"_T7","span":{"begin":144,"end":151},"obj":"FMAID:67257"},{"id":"_T8","span":{"begin":144,"end":151},"obj":"FMAID:165447"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T1","span":{"begin":105,"end":126},"obj":"http://www.uniprot.org/uniprot/P06280"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    uniprot-mouse

    {"project":"uniprot-mouse","denotations":[{"id":"T1","span":{"begin":105,"end":126},"obj":"http://www.uniprot.org/uniprot/P51569"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T2","span":{"begin":51,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0051235"},{"id":"T4","span":{"begin":51,"end":58},"obj":"http://purl.obolibrary.org/obo/GO_0035732"},{"id":"T5","span":{"begin":105,"end":124},"obj":"http://purl.obolibrary.org/obo/GO_0004557"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    GO-CC

    {"project":"GO-CC","denotations":[{"id":"T1","span":{"begin":41,"end":50},"obj":"http://purl.obolibrary.org/obo/GO_0005764"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    EDAM-topics

    {"project":"EDAM-topics","denotations":[{"id":"T2","span":{"begin":13,"end":20},"obj":"http://edamontology.org/topic_0634"},{"id":"T3","span":{"begin":28,"end":35},"obj":"http://edamontology.org/topic_0634"},{"id":"T4","span":{"begin":41,"end":50},"obj":"http://edamontology.org/topic_0616"},{"id":"T5","span":{"begin":59,"end":66},"obj":"http://edamontology.org/topic_0634"},{"id":"T6","span":{"begin":144,"end":151},"obj":"http://edamontology.org/topic_0078"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    EDAM-DFO

    {"project":"EDAM-DFO","denotations":[{"id":"T2","span":{"begin":144,"end":151},"obj":"http://edamontology.org/format_1208"},{"id":"T3","span":{"begin":144,"end":151},"obj":"http://edamontology.org/data_1467"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    DisGeNET5_gene_disease

    {"project":"DisGeNET5_gene_disease","denotations":[{"id":"12626384-1#83#104#gene2717","span":{"begin":105,"end":126},"obj":"gene2717"},{"id":"12626384-1#0#13#diseaseC0002986","span":{"begin":22,"end":35},"obj":"diseaseC0002986"},{"id":"12626384-1#19#44#diseaseC0085078","span":{"begin":41,"end":66},"obj":"diseaseC0085078"}],"relations":[{"id":"83#104#gene27170#13#diseaseC0002986","pred":"associated_with","subj":"12626384-1#83#104#gene2717","obj":"12626384-1#0#13#diseaseC0002986"},{"id":"83#104#gene271719#44#diseaseC0085078","pred":"associated_with","subj":"12626384-1#83#104#gene2717","obj":"12626384-1#19#44#diseaseC0085078"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    DisGeNET

    {"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":105,"end":126},"obj":"gene:2717"},{"id":"T1","span":{"begin":22,"end":35},"obj":"disease:C0002986"},{"id":"T2","span":{"begin":105,"end":126},"obj":"gene:2717"},{"id":"T3","span":{"begin":41,"end":66},"obj":"disease:C0085078"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"},{"id":"R2","pred":"associated_with","subj":"T2","obj":"T3"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":7,"end":20},"obj":"Disease"},{"id":"T2","span":{"begin":22,"end":35},"obj":"Disease"},{"id":"T3","span":{"begin":41,"end":66},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0010526"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0010526"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0002561"}],"text":"sorder Fabry disease.\nFabry disease is a lysosomal storage disease arising from deficiency of the enzyme alpha-galactosidase A. Two recombinant protein therapeutics, Fabrazyme ("}